{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:28:53Z","timestamp":1786336133867,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000106","name":"Saskatchewan Health Research Foundation","doi-asserted-by":"publisher","award":["SHRF #6322"],"award-info":[{"award-number":["SHRF #6322"]}],"id":[{"id":"10.13039\/501100000106","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canadian Institutes for Health Research (CIHR) Pan-Canadian Network for HIV and STBBI Clinical Trials Research","award":["CTN+ #343"],"award-info":[{"award-number":["CTN+ #343"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The opioid crisis is a major public health issue in Canada, with prairie provinces such as Saskatchewan experiencing particularly high rates of opioid-related harms. Factors contributing to this crisis include an unstable drug supply, limited access to harm reduction services, and structural challenges such as poverty and housing instability. The rise of fentanyl has further exacerbated overdose risks, particularly among people who use drugs. Harm reduction programs, such as opioid overdose education and naloxone distribution, have proven effective in reducing overdose fatalities and improving community health. While geospatial analysis has shown promise in identifying areas of high need for targeted harm reduction interventions, its integration into harm reduction strategies remains underexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study utilized data from 44 participants who completed pop-up naloxone training sessions in Regina, Saskatchewan, between August 2023 and September 2024. Data sources include geospatial information on discarded needles from the ReportNeedles.ca platform and survey responses evaluating opioid overdose and naloxone administration using a modified Opioid Overdose Knowledge Scale. Naloxone training sessions were targeted to areas with a high number of discarded needles determined by the ReportNeedles.ca platform. Geospatial analyses were conducted using ArcGIS to map needle prevalence and assess the accessibility of harm reduction services based on walk-time buffers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between August 2023 and August 2024, 315 reports on ReportNeedles.ca led to the disposal of 2,836 needles. Geospatial analysis revealed clustering of discarded needles in Regina\u2019s city center, with some seasonal variation. Pop-up training sites expanded the accessibility of naloxone services, with 70% of participants reporting living within a 15-minute walk to pop-up Naloxone trainings. However, geospatial analysis revealed gaps in service accessibility specifically in suburban areas. Participants in pop-up naloxone trainings demonstrated strong knowledge of overdose recognition and naloxone administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates potential benefit in integrating geospatial analysis with harm reduction interventions to address the opioid crisis. By identifying needle prevalence hotspots and utilizing pop-up naloxone training, service providers can improve service accessibility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-026-01477-z","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:06:13Z","timestamp":1780589173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mapping needles, reducing harm: Findings from a geospatial, community-based needle collection and naloxone training initiative in Saskatchewan, Canada"],"prefix":"10.1186","volume":"23","author":[{"given":"Nelson","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiny Mary","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya Dhar","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tashia","family":"Acoose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Hidlebaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Shuper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ib\u00e1\u00f1ez-Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"issue":"1","key":"1477_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/07067437231188202","volume":"69","author":"RM Krausz","year":"2024","unstructured":"Krausz RM, Westenberg JN, Tai AMY, Fadakar H, Seethapathy V, Mathew N, et al. A Call for an Evidence-Based Strategy Against the Overdose Crisis. Can J Psychiatry. 2024;69(1):5\u20139.","journal-title":"Can J Psychiatry"},{"issue":"2","key":"1477_CR2","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/S2468-2667(18)30232-9","volume":"4","author":"B Fischer","year":"2019","unstructured":"Fischer B, Pang M, Tyndall M. The opioid death crisis in Canada: crucial lessons for public health. Lancet Public Health. 2019;4(2):e81\u20132.","journal-title":"Lancet Public Health"},{"issue":"7","key":"1477_CR3","doi-asserted-by":"publisher","first-page":"e0306395","DOI":"10.1371\/journal.pone.0306395","volume":"19","author":"R Laing","year":"2024","unstructured":"Laing R, Donnelly CA. Evolution of an epidemic: Understanding the opioid epidemic in the United States and the impact of the COVID-19 pandemic on opioid-related mortality. PLoS ONE. 2024;19(7):e0306395.","journal-title":"PLoS ONE"},{"issue":"1","key":"1477_CR4","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1192\/j.eurpsy.2021.2219","volume":"64","author":"M Pierce","year":"2021","unstructured":"Pierce M, van Amsterdam J, Kalkman GA, Schellekens A, van den Brink W. Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018. Eur Psychiatry. 2021;64(1):e47.","journal-title":"Eur Psychiatry"},{"key":"1477_CR5","doi-asserted-by":"publisher","first-page":"104339","DOI":"10.1016\/j.drugpo.2024.104339","volume":"125","author":"S Ledlie","year":"2024","unstructured":"Ledlie S, Garg R, Cheng C, Kolla G, Antoniou T, Bouck Z, et al. Prescribed safer opioid supply: A scoping review of the evidence. Int J Drug Policy. 2024;125:104339.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"1477_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/ijerph21040442","volume":"21","author":"R Zahan","year":"2024","unstructured":"Zahan R, Osgood ND, Plouffe R, Orpana H. A Dynamic Model of Opioid Overdose Deaths in Canada during the Co-Occurring Opioid Overdose Crisis and COVID-19 Pandemic. Int J Environ Res Public Health. 2024;21(4):442.","journal-title":"Int J Environ Res Public Health"},{"key":"1477_CR7","unstructured":"Public Health Agency of Canada. Key findings: Opioid- and Stimulant-related Harms in Canada \u2014 Canada.ca [Internet]. 2019 [cited 2025 Jan 13]. Available from: https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/"},{"key":"1477_CR8","unstructured":"Novotna G, Camillo C, Cooper E, McIntosh T, Stewart M. Evidence-Informed Responses to Evolving Opioid-Related Harms in the Province of Saskatchewan. Saskatchewan Population Health and Evaluation Research Unit; 2021 Oct."},{"key":"1477_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugpo.2019.07.030","volume":"73","author":"S Colledge","year":"2019","unstructured":"Colledge S, Peacock A, Leung J, Larney S, Grebely J, Hickman M, et al. The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis. Int J Drug Policy. 2019;73:172\u201384.","journal-title":"Int J Drug Policy"},{"key":"1477_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.drugpo.2019.01.002","volume":"67","author":"SE Collins","year":"2019","unstructured":"Collins SE, Clifasefi SL, Nelson LA, Stanton J, Goldstein SC, Taylor EM, et al. Randomized controlled trial of harm reduction treatment for alcohol (HaRT-A) for people experiencing homelessness and alcohol use disorder. Int J Drug Policy. 2019;67:24\u201333.","journal-title":"Int J Drug Policy"},{"key":"1477_CR11","doi-asserted-by":"crossref","unstructured":"Rezaei S, Hajizadeh M, Ahmadi S, Ebrahimi M, Karami Matin B. Socioeconomic inequality in self-medication in Iran: Cross-sectional analyses at the national and subnational levels. Clin Outcomes Res. 2020;411\u201321.","DOI":"10.2147\/CEOR.S252244"},{"key":"1477_CR12","doi-asserted-by":"crossref","unstructured":"Wills TA. Stress and coping factors in the epidemiology of substance use. Research Advances in Alcohol and Drug Problems: 10. Springer; 1990. 215\u201350.","DOI":"10.1007\/978-1-4899-1669-3_7"},{"key":"1477_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1477-7517-3-30","volume":"3","author":"D Wardman","year":"2006","unstructured":"Wardman D, Quantz D. Harm reduction services for British Columbia\u2019s First Nation population: a qualitative inquiry into opportunities and barriers for injection drug users. Harm Reduct J. 2006;3:30.","journal-title":"Harm Reduct J"},{"issue":"3","key":"1477_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/1533256X.2022.2049161","volume":"22","author":"A Richer","year":"2022","unstructured":"Richer A, Roddy AL. Opioid use in indigenous populations: indigenous perspectives and directions in culturally responsive care. J Soc Work Pract Addict. 2022;22(3):255\u201363.","journal-title":"J Soc Work Pract Addict"},{"key":"1477_CR15","unstructured":"Eaton A, Kwan S. The dire quality of life in Saskatchewan, Canada. Canadian Review of. Social Policy. (In press)."},{"key":"1477_CR16","unstructured":"Government of Saskatchewan. Fostering Positive Collaboration: Urban Reserve Creation in Saskatchewan [Internet]. Regina (SK): Government of Saskatchewan; [cited 2026 Feb 4]. Available from: https:\/\/www.saskatchewan.ca\/government\/partnerships-for-success\/profiles\/urban-reserve-creation"},{"key":"1477_CR17","unstructured":"Western Economic Diversification Canada, Saskatchewan Region. Urban reserves in Saskatchewan [Internet]. Ottawa (ON): Government of Canada; 2005 [cited 2026 Feb 4]. Available from: https:\/\/publications.gc.ca\/collections\/collection_2016\/deo-wd\/Iu92-4-36-2005-eng.pdf"},{"key":"1477_CR18","doi-asserted-by":"publisher","first-page":"103237","DOI":"10.1016\/j.drugpo.2021.103237","volume":"93","author":"F Ali","year":"2021","unstructured":"Ali F, Russell C, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada. Int J Drug Policy. 2021;93:103237.","journal-title":"Int J Drug Policy"},{"key":"1477_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","volume":"171","author":"J Suzuki","year":"2017","unstructured":"Suzuki J, El-Haddad S. A review: Fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend. 2017;171:107\u201316.","journal-title":"Drug Alcohol Depend"},{"key":"1477_CR20","doi-asserted-by":"publisher","first-page":"104063","DOI":"10.1016\/j.drugpo.2023.104063","volume":"118","author":"C McKnight","year":"2023","unstructured":"McKnight C, Weng CA, Reynoso M, Kimball S, Thompson LM, Jarlais DD. Understanding intentionality of fentanyl use and drug overdose risk: Findings from a mixed methods study of people who inject drugs in New York City. Int J Drug Policy. 2023;118:104063.","journal-title":"Int J Drug Policy"},{"key":"1477_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.drugalcdep.2018.09.006","volume":"193","author":"S Mayer","year":"2018","unstructured":"Mayer S, Boyd J, Collins A, Kennedy MC, Fairbairn N, McNeil R. Characterizing fentanyl-related overdoses and implications for overdose response: Findings from a rapid ethnographic study in Vancouver, Canada. Drug Alcohol Depend. 2018;193:69\u201374.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1477_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1477-7517-6-26","volume":"6","author":"RL Gaston","year":"2009","unstructured":"Gaston RL, Best D, Manning V, Day E. Can we prevent drug related deaths by training opioid users to recognise and manage overdoses? Harm Reduct J. 2009;6(1):26.","journal-title":"Harm Reduct J"},{"issue":"3","key":"1477_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/ajad.12364","volume":"25","author":"DC Lott","year":"2016","unstructured":"Lott DC, Rhodes J. Opioid overdose and naloxone education in a substance use disorder treatment program. Am J Addict. 2016;25(3):221\u20136.","journal-title":"Am J Addict"},{"issue":"1","key":"1477_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12954-022-00639-z","volume":"19","author":"LD Wenger","year":"2022","unstructured":"Wenger LD, Doe-Simkins M, Wheeler E, Ongais L, Morris T, Bluthenthal RN, et al. Best practices for community-based overdose education and naloxone distribution programs: results from using the Delphi approach. Harm Reduct J. 2022;19(1):55.","journal-title":"Harm Reduct J"},{"issue":"8","key":"1477_CR25","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/add.12961","volume":"110","author":"C Rowe","year":"2015","unstructured":"Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program. Addict Abingdon Engl. 2015;110(8):1301\u201310.","journal-title":"Addict Abingdon Engl"},{"issue":"3","key":"1477_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/JAN.0000000000000235","volume":"29","author":"LM Pietrusza","year":"2018","unstructured":"Pietrusza LM, Puskar KR, Ren D, Mitchell AM. Evaluation of an Opiate Overdose Educational Intervention and Naloxone Prescribing Program in Homeless Adults Who Use Opiates. J Addict Nurs. 2018;29(3):188\u201395.","journal-title":"J Addict Nurs"},{"issue":"4","key":"1477_CR27","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/1742-6723.13925","volume":"34","author":"E Black","year":"2022","unstructured":"Black E, Monds LA, Chan B, Brett J, Hutton JE, Acheson L, et al. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with \u2018take-home naloxone\u2019 in emergency departments. Emerg Med Australas. 2022;34(4):509\u201318.","journal-title":"Emerg Med Australas"},{"key":"1477_CR28","doi-asserted-by":"publisher","first-page":"108325","DOI":"10.1016\/j.drugalcdep.2020.108325","volume":"217","author":"T Winhusen","year":"2020","unstructured":"Winhusen T, Walley A, Fanucchi LC, Hunt T, Lyons M, Lofwall M, et al. The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study. Drug Alcohol Depend. 2020;217:108325.","journal-title":"Drug Alcohol Depend"},{"key":"1477_CR29","unstructured":"Maxwell S. Prescribing Naloxone to Actively Injecting Heroin Users. J Addict Dis [Internet]. 2006 Oct 17 [cited 2024 Dec 13]; Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.1300\/J069v25n03_11"},{"key":"1477_CR30","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","volume":"346","author":"AY Walley","year":"2013","unstructured":"Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.","journal-title":"BMJ"},{"issue":"7","key":"1477_CR31","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s11606-015-3209-6","volume":"30","author":"SB Trooskin","year":"2015","unstructured":"Trooskin SB, Poceta J, Towey CM, Yolken A, Rose JS, Luqman NL, et al. Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation Program. J Gen Intern Med. 2015;30(7):950\u20137.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"1477_CR32","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1007\/s10461-019-02467-y","volume":"23","author":"D Des Jarlais","year":"2019","unstructured":"Des Jarlais D, Uuskula A, Talu A, Barnes DM, Raag M, Arasteh K, et al. Implementing an Updated Break the Cycle Intervention to Reduce Initiating Persons into Injecting Drug Use in an Eastern European and a US opioid epidemic Setting. AIDS Behav. 2019;23(9):2304\u201314.","journal-title":"AIDS Behav"},{"issue":"3","key":"1477_CR33","doi-asserted-by":"publisher","first-page":"e0175115","DOI":"10.1371\/journal.pone.0175115","volume":"12","author":"DA Dworkis","year":"2017","unstructured":"Dworkis DA, Taylor LA, Peak DA, Bearnot B. Geospatial analysis of emergency department visits for targeting community-based responses to the opioid epidemic. PLoS ONE. 2017;12(3):e0175115.","journal-title":"PLoS ONE"},{"issue":"4","key":"1477_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.5811\/westjem.2018.4.37054","volume":"19","author":"DA Dworkis","year":"2018","unstructured":"Dworkis DA, Weiner SG, Liao VT, Rabickow D, Goldberg SA. Geospatial Clustering of Opioid-Related Emergency Medical Services Runs for Public Deployment of Naloxone. West J Emerg Med. 2018;19(4):641\u20138.","journal-title":"West J Emerg Med"},{"key":"1477_CR35","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.1038\/s41598-021-84148-2","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X, Hou W, Rashidian S, Wang Y, Zhao X, Leibowitz GS, et al. A large-scale retrospective study of opioid poisoning in New York State with implications for targeted interventions. Sci Rep. 2021;11:5152.","journal-title":"Sci Rep"},{"key":"1477_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1477-7517-7-14","volume":"7","author":"NS Wong","year":"2010","unstructured":"Wong NS, Lee SS, Lin H. Assessing the spatial distribution of methadone clinic clients and their access to treatment. Harm Reduct J. 2010;7:14.","journal-title":"Harm Reduct J"},{"issue":"4","key":"1477_CR37","doi-asserted-by":"publisher","first-page":"e32133","DOI":"10.2196\/32133","volume":"8","author":"K Abell-Hart","year":"2022","unstructured":"Abell-Hart K, Rashidian S, Teng D, Rosenthal RN, Wang F. Where Opioid Overdose Patients Live Far From Treatment: Geospatial Analysis of Underserved Populations in New York State. JMIR Public Health Surveill. 2022;8(4):e32133.","journal-title":"JMIR Public Health Surveill"},{"key":"1477_CR38","doi-asserted-by":"crossref","unstructured":"Eaton AD, Pang N, Varghese SM, Reddy VD, Ross S, Novotna G et al. ReportNeedles. ca: A real-time needle collection tool to foster community health partnerships. Prog Community Health Partnersh. 2024.","DOI":"10.21203\/rs.3.rs-3332760\/v1"},{"issue":"1","key":"1477_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.drugalcdep.2013.02.007","volume":"132","author":"AV Williams","year":"2013","unstructured":"Williams AV, Strang J, Marsden J. Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation. Drug Alcohol Depend. 2013;132(1):383\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1477_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/08897077.2015.1110550","volume":"37","author":"L Ashrafioun","year":"2016","unstructured":"Ashrafioun L, Gamble S, Herrmann M, Baciewicz G. Evaluation of knowledge and confidence following opioid overdose prevention training: A comparison of types of training participants and naloxone administration methods. Subst Abuse. 2016;37(1):76\u201381.","journal-title":"Subst Abuse"},{"key":"1477_CR41","doi-asserted-by":"crossref","unstructured":"Levine S, Medley A, Norton A. Putting Indigenous Harm Reduction to Work: Developing and Evaluating Not Just Naloxone. Int J Indig Health [Internet]. 2021 Jan 25 [cited 2024 Dec 13];16(2).","DOI":"10.32799\/ijih.v16i2.33346"},{"key":"1477_CR42","unstructured":"Harwerth J. Transportation Barriers for Substance Abuse and Mental Health Outpatient Treatment Programs: a Scoping Review. Soc Work Theses [Internet]; 2020."},{"issue":"1","key":"1477_CR43","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s40337-024-01098-6","volume":"12","author":"N Pang","year":"2024","unstructured":"Pang N, Nagata JM, Testa A, Ganson KT. Mapping eating disorders in adolescents and young adults: an investigation of geographic distribution and access to care in Ontario, Canada. J Eat Disord. 2024;12(1):136.","journal-title":"J Eat Disord"},{"issue":"2","key":"1477_CR44","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/S2468-2667(23)00300-6","volume":"9","author":"I Rammohan","year":"2024","unstructured":"Rammohan I, Gaines T, Scheim A, Bayoumi A, Werb D. Overdose mortality incidence and supervised consumption services in Toronto, Canada: an ecological study and spatial analysis. Lancet Public Health. 2024;9(2):e79\u201387.","journal-title":"Lancet Public Health"},{"key":"1477_CR45","doi-asserted-by":"publisher","first-page":"100288","DOI":"10.1016\/j.sste.2019.100288","volume":"30","author":"O Amram","year":"2019","unstructured":"Amram O, Soc\u00edas E, Nosova E, Kerr T, Wood E, DeBeck K, et al. Density of low-barrier opioid agonist clinics and risk of non-fatal overdose during a community-wide overdose crisis: A spatial analysis. Spat Spatio-Temporal Epidemiol. 2019;30:100288.","journal-title":"Spat Spatio-Temporal Epidemiol"},{"key":"1477_CR46","doi-asserted-by":"publisher","first-page":"102623","DOI":"10.1016\/j.drugpo.2019.102623","volume":"76","author":"M Selfridge","year":"2020","unstructured":"Selfridge M, Greer A, Card KG, Macdonald S, Pauly B. It\u2019s like super structural - Overdose experiences of youth who use drugs and police in three non-metropolitan cities across British Columbia. Int J Drug Policy. 2020;76:102623.","journal-title":"Int J Drug Policy"},{"key":"1477_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12954-019-0285-7","volume":"16","author":"S Chan Carusone","year":"2019","unstructured":"Chan Carusone S, Guta A, Robinson S, Tan DH, Cooper C, O\u2019Leary B, et al. Maybe if I stop the drugs, then maybe they\u2019d care?\u2014hospital care experiences of people who use drugs. Harm Reduct J. 2019;16:16.","journal-title":"Harm Reduct J"},{"key":"1477_CR48","doi-asserted-by":"crossref","unstructured":"Dezfulian C, Orkin AM, Maron BA, Elmer J, Girotra S, Gladwin MT et al. Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association. Circulation [Internet]. 2021 Apr 20 [cited 2024 Dec 16].","DOI":"10.1161\/CIR.0000000000000958"},{"key":"1477_CR49","unstructured":"Public Health Agency of. Estimates of HIV incidence, prevalence and Canada\u2019s progress on meeting the 90-90-90 HIV targets, 2020 [Internet]. 2022 Jul [cited 2024 Dec 16]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/estimates-hiv-incidence-prevalence-canada-meeting-90-90-90-targets-2020.html."},{"issue":"8","key":"1477_CR50","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/QAD.0000000000001792","volume":"32","author":"G Meyer-Rath","year":"2018","unstructured":"Meyer-Rath G, McGillen JB, Cuadros DF, Hallett TB, Bhatt S, Wabiri N, et al. Targeting the right interventions to the right people and places: the role of geospatial analysis in HIV program planning. AIDS. 2018;32(8):957.","journal-title":"AIDS"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-026-01477-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01477-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01477-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:53:36Z","timestamp":1786334016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-026-01477-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1477"],"URL":"https:\/\/doi.org\/10.1186\/s12954-026-01477-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5836079\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethics approval from the Research Ethics Board at the University of Regina (#236).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"129"}}